Results 131 to 140 of about 13,327 (170)

[Atypical clinical and mortality in older adults hospitalized with COVID-19 pneumonia]. [PDF]

Rev Med Inst Mex Seguro Soc
Valencia-Blancas T, Pérez-Orozco LH, Durán-Gómez V, García-Barboza E, López-Anguiano RR.   +4 more
europepmc   +1 more source

[Emerging Nutritional Interventions for Irritable Bowel Syndrome: Starch- and Sucrose-Reduced Diet and Mediterranean Diet]. [PDF]

Acta Gastroenterol Latinoam
Schaab SN, Gutiérrez MC.
europepmc   +1 more source

[Abdominal pain and inconclusive ultrasound: a CT scan may not always be the best next step] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Moreno-Alfonso JC, Hernández Martín S, Ayuso González L, Perez Martínez A.   +3 more
europepmc   +1 more source

[Clostridiodes difficile bacteraemia. First mexican case report]. [PDF]

Rev Med Inst Mex Seguro Soc
González-Godínez I, Carrillo-Vázquez E, Garduño-Ortíz AL, Chacón-Hernández SE, Hevia-Del Cabrera HA.   +4 more
europepmc   +1 more source

Infectious etiology and indicators of malabsorption or intestinal injury in childhood diarrhea. [PDF]

Biomedica
Martins AS, Santos SA, Lisboa CADS, Barros TF, Ribeiro TCM, Da Costa-Ribeiro H, Mattos ÂP, Almeida Mendes PS, Mendes CMC, Souza EL, Moreno Amor AL, Soares NM, Aquino Teixeira MC.   +12 more
europepmc   +1 more source

Clinical and genetic description of patients with chronic granulomatous disease in a pediatric hospital [PDF]

Biomedica
Berriozábal-Villarruel X, Godínez-Zamora GF, Baeza-Capetillo P, Pérez-Blanco U, Espinosa-Padilla SE, Aguirre-Hernández J, Blancas-Galicia L, Saucedo-Ramírez OJ.   +7 more
europepmc   +1 more source

The incidence and antimicrobial resistance of Shigella-attributable diarrhoea in young children in low-income and middle-income countries from the multicountry Enterics for Global Health (EFGH) Shigella Surveillance Study: a prospective, facility-based hybrid surveillance study.

Lancet Glob Health
Yousafzai MT, Cornick J, Penataro Yori P, Hossain MJ, Keita AM, Atlas HE, Khanam F, Omore R, Galagan SR, Ahmed N, Ahmmed F, Awuor AO, Badji H, Conteh B, Garcia Quesada M, Garcia-Bardales PF, Horne B, Hotwani A, Houpt ER, Islam MT, Jere KC, Juma J, Liu J, Mategula D, Ogwel B, Okonji C, Onwuchekwa UU, Paredes Olortegui M, Platts-Mills JA, Qureshi S, Rajib MNH, Rogawski McQuade ET, Schiaffino F, Secka O, Sow SO, Witte D, Kotloff KL, Cunliffe NA, Clemens JD, Tennant SM, Qamar FN, Kosek MN, Pavlinac PB, Tapia MD, Ochieng JB, EFGH Consortium.   +45 more
europepmc   +1 more source

[Clinical profile of patients with secondary immunodeficiency on immunoglobulin replacement therapy]. [PDF]

Rev Med Inst Mex Seguro Soc
Méndez-Gómez A, Gómez-Hernández N, Ortega-Cisneros M, Gutiérrez-Zepeda BM, Quintero-Rodríguez AJ, Duran-Marín LA, Rosaldo-Solís ML, Quintero-Ramos A.   +7 more
europepmc   +1 more source

[Adverse reactions of GLP-1 inhibitors when used to treat obesity in non-diabetic patients]. [PDF]

Aten Primaria
Barceló Colomer ME, Fernández Liz E.
europepmc   +1 more source

[Evaluation of the management of Clostridioides difficile infection as a risk factor for recurrence. A retrospective observational study]. [PDF]

Rev Esp Quimioter
Barbero Allende JM, Ureña I, Cañivano L, García S, Paz C, Olmo-Ruiloba A, Jauregi K, Coronado S, López Requejo L, Porcel L, Perea V, Irigoyen M, Cano J, García A, León E, Fernández-Domingo N, Lanchares P, Lino B, Ortolá M, Lizasoain A, Sánchez V, Arévalo-Cañas C, Arévalo-Serrano J.   +22 more
europepmc   +1 more source